Pierre Raboisson

机构：Achieve Life Sciences (Canada)

发表论文 127 篇 · 总被引 4118 次 · h-index 37

代表论文

• A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction (2021 · Nature · 被引 203)
• The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir (2023 · mBio · 被引 179)
• A small-molecule fusion inhibitor of influenza virus is orally active in mice (2019 · Science · 被引 149)
• Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates (2023 · Nature · 被引 136)
• Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor (2017 · Nature Communications · 被引 100)
• Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH) (2020 · PLoS ONE · 被引 75)